Next Article in Journal
Impact of Maternal Daily Oral Low-Dose Vitamin A Supplementation on the Mother-Infant Pair: A Randomised Placebo-Controlled Trial in China
Next Article in Special Issue
Differences in the Concentration of Vitamin D Metabolites in Plasma Due to the Low-Carbohydrate-High-Fat Diet and the Eastern European Diet—A Pilot Study
Previous Article in Journal
Dietary Spray-Dried Porcine Plasma Reduces Neuropathological Alzheimer’s Disease Hallmarks in SAMP8 Mice
Previous Article in Special Issue
Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity
Article

Ex Vivo Evaluation of the Sepsis Triple Therapy High-Dose Vitamin C in Combination with Vitamin B1 and Hydrocortisone in a Human Peripheral Blood Mononuclear Cells (PBMCs) Model

1
Division of Dermatooncology, Department of Dermatology, University of Tübingen, 72076 Tübingen, Germany
2
Institute of Nutritional Sciences, Nutritional Biochemistry, University of Hohenheim, 70599 Stuttgart, Germany
3
Cluster of Excellence iFIT (EXC 2180) “Image Guided and Functionally Instructed Tumor Therapies”, 72076 Tübingen, Germany
4
Pascoe Pharmazeutische Praeparate GmbH, 35394 Giessen, Germany
5
Dermatologie zum Delfin, 8400 Winterthur, Switzerland
6
Institute of Physiology, Department of Vegetative and Clinical Physiology, University of Tübingen, 72024 Tübingen, Germany
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editors: Premysl Mladenka and Carol Johnston
Nutrients 2021, 13(7), 2366; https://doi.org/10.3390/nu13072366
Received: 1 June 2021 / Revised: 30 June 2021 / Accepted: 8 July 2021 / Published: 10 July 2021
Sepsis is an extremely complex clinical syndrome, usually involving an excessive inflammatory response including an overshooting cytokine release that damages tissue and organs of the patient. Due to the severity of this condition, it is estimated that over 11 million people die from sepsis each year. Despite intensive research in the field, there is still no specific therapy for sepsis. Many sepsis patients show a marked deficiency of vitamin C. 9 out of 10 sepsis patients have a hypovitaminosis C, and every third patient even shows a clinical deficiency in the scurvy range. In addition, low vitamin C levels of intensive care sepsis patients correlate with a higher need for vasopressors, higher Sequential Organ Failure Assessment (SOFA) scores, and increased mortality. Based on this observation and the conducted clinical trials using vitamin C as sepsis therapy in intensive care patients, the aim of the present ex vivo study was to evaluate the effects of high-dose vitamin C alone and in a triple combination supplemented with vitamin B1 (thiamine) and hydrocortisone on the lipopolysaccharide (LPS)-induced cytokine response in peripheral blood mononuclear cells (PBMCs) from healthy human donors. We found that all corticosteroid combinations strongly reduced the cytokine response on RNA- and protein levels, while high-dose vitamin C alone significantly diminished the PBMC mediated secretion of the cytokines interleukin (IL)-10, IL-23, and monocyte chemo-attractant protein (MCP-1), which mediate the inflammatory response. However, vitamin C showed no enhancing effect on the secretion of further cytokines studied. This data provides important insights into the possible immunomodulatory function of vitamin C in an ex vivo setting of human PBMCs and the modulation of their cytokine profile in the context of sepsis. Since vitamin C is a vital micronutrient, the restoration of physiologically adequate concentrations should be integrated into routine sepsis therapy, and the therapeutic effects of supraphysiological concentrations of vitamin C in sepsis patients should be further investigated in clinical trials. View Full-Text
Keywords: vitamin C; vitamin B1; hydrocortisone; sepsis; cytokine release vitamin C; vitamin B1; hydrocortisone; sepsis; cytokine release
Show Figures

Figure 1

MDPI and ACS Style

Lauer, A.; Burkard, M.; Niessner, H.; Leischner, C.; Renner, O.; Vollbracht, C.; Michels, H.; Busch, C.; Sinnberg, T.; Venturelli, S. Ex Vivo Evaluation of the Sepsis Triple Therapy High-Dose Vitamin C in Combination with Vitamin B1 and Hydrocortisone in a Human Peripheral Blood Mononuclear Cells (PBMCs) Model. Nutrients 2021, 13, 2366. https://doi.org/10.3390/nu13072366

AMA Style

Lauer A, Burkard M, Niessner H, Leischner C, Renner O, Vollbracht C, Michels H, Busch C, Sinnberg T, Venturelli S. Ex Vivo Evaluation of the Sepsis Triple Therapy High-Dose Vitamin C in Combination with Vitamin B1 and Hydrocortisone in a Human Peripheral Blood Mononuclear Cells (PBMCs) Model. Nutrients. 2021; 13(7):2366. https://doi.org/10.3390/nu13072366

Chicago/Turabian Style

Lauer, Annie, Markus Burkard, Heike Niessner, Christian Leischner, Olga Renner, Claudia Vollbracht, Holger Michels, Christian Busch, Tobias Sinnberg, and Sascha Venturelli. 2021. "Ex Vivo Evaluation of the Sepsis Triple Therapy High-Dose Vitamin C in Combination with Vitamin B1 and Hydrocortisone in a Human Peripheral Blood Mononuclear Cells (PBMCs) Model" Nutrients 13, no. 7: 2366. https://doi.org/10.3390/nu13072366

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop